118 related articles for article (PubMed ID: 38270934)
1. Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line.
Ulanova M; Gloag L; Kim CK; Bongers A; Kim Duong HT; Gooding JJ; Tilley RD; Sachdev PS; Braidy N
Nanomedicine (Lond); 2024 Feb; 19(4):303-323. PubMed ID: 38270934
[TBL] [Abstract][Full Text] [Related]
2. A value-added exopolysaccharide as a coating agent for MRI nanoprobes.
Palma SI; Rodrigues CA; Carvalho A; Morales Mdel P; Freitas F; Fernandes AR; Cabral JM; Roque AC
Nanoscale; 2015 Sep; 7(34):14272-83. PubMed ID: 26186402
[TBL] [Abstract][Full Text] [Related]
3. 2, 3-dimercaptosuccinic acid-modified iron oxide clusters for magnetic resonance imaging.
Xiong F; Yan C; Tian J; Geng K; Zhu Z; Song L; Zhang Y; Mulvale M; Gu N
J Pharm Sci; 2014 Dec; 103(12):4030-4037. PubMed ID: 25335461
[TBL] [Abstract][Full Text] [Related]
4. Labeling mesenchymal cells with DMSA-coated gold and iron oxide nanoparticles: assessment of biocompatibility and potential applications.
Silva LH; da Silva JR; Ferreira GA; Silva RC; Lima EC; Azevedo RB; Oliveira DM
J Nanobiotechnology; 2016 Jul; 14(1):59. PubMed ID: 27431051
[TBL] [Abstract][Full Text] [Related]
5. Europium-engineered iron oxide nanocubes with high T1 and T2 contrast abilities for MRI in living subjects.
Yang L; Zhou Z; Liu H; Wu C; Zhang H; Huang G; Ai H; Gao J
Nanoscale; 2015 Apr; 7(15):6843-50. PubMed ID: 25806860
[TBL] [Abstract][Full Text] [Related]
6. MRI of High-Glucose Metabolism Tumors: a Study in Cells and Mice with 2-DG-Modified Superparamagnetic Iron Oxide Nanoparticles.
Shan XH; Wang P; Xiong F; Gu N; Hu H; Qian W; Lu HY; Fan Y
Mol Imaging Biol; 2016 Feb; 18(1):24-33. PubMed ID: 26150194
[TBL] [Abstract][Full Text] [Related]
7. DMSA-Coated Iron Oxide Nanoparticles Greatly Affect the Expression of Genes Coding Cysteine-Rich Proteins by Their DMSA Coating.
Zhang L; Wang X; Zou J; Liu Y; Wang J
Chem Res Toxicol; 2015 Oct; 28(10):1961-74. PubMed ID: 26378955
[TBL] [Abstract][Full Text] [Related]
8. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
Shan X; Yuan D; Xiong F; Gu N; Wang P
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
[TBL] [Abstract][Full Text] [Related]
9. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
[TBL] [Abstract][Full Text] [Related]
10. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
[TBL] [Abstract][Full Text] [Related]
11. Detection of human breast cancer cells using a 2-deoxy-D-glucose-functionalized superparamagnetic iron oxide nanoparticles.
Shan XH; Wang P; Xiong F; Lu HY; Hu H
Cancer Biomark; 2017; 18(4):367-374. PubMed ID: 28106540
[TBL] [Abstract][Full Text] [Related]
12. Characterization of interaction of magnetic nanoparticles with breast cancer cells.
Calero M; Chiappi M; Lazaro-Carrillo A; Rodríguez MJ; Chichón FJ; Crosbie-Staunton K; Prina-Mello A; Volkov Y; Villanueva A; Carrascosa JL
J Nanobiotechnology; 2015 Feb; 13():16. PubMed ID: 25880445
[TBL] [Abstract][Full Text] [Related]
13. Pheomelanin-coated iron oxide magnetic nanoparticles: a promising candidate for negative T2 contrast enhancement in magnetic resonance imaging.
Zottis AD; Beltrame JM; Lara LR; Costa TG; Feldhaus MJ; Pedrosa RC; Ourique F; de Campos CE; Isoppo Ede A; da Silva Miranda F; Szpoganicz B
Chem Commun (Camb); 2015 Jun; 51(56):11194-7. PubMed ID: 26073290
[TBL] [Abstract][Full Text] [Related]
14. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
15. Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications.
Mejías R; Gutiérrez L; Salas G; Pérez-Yagüe S; Zotes TM; Lázaro FJ; Morales MP; Barber DF
J Control Release; 2013 Oct; 171(2):225-33. PubMed ID: 23906866
[TBL] [Abstract][Full Text] [Related]
16. Covalent coupling of gum arabic onto superparamagnetic iron oxide nanoparticles for MRI cell labeling: physicochemical and in vitro characterization.
Palma SI; Carvalho A; Silva J; Martins P; Marciello M; Fernandes AR; del Puerto Morales M; Roque AC
Contrast Media Mol Imaging; 2015; 10(4):320-8. PubMed ID: 25766788
[TBL] [Abstract][Full Text] [Related]
17. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
18. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
[TBL] [Abstract][Full Text] [Related]
19. DMSA-coated cubic iron oxide nanoparticles as potential therapeutic agents.
Çitoğlu S; Coşkun ÖD; Tung LD; Onur MA; Thanh NTK
Nanomedicine (Lond); 2021 May; 16(11):925-941. PubMed ID: 34015971
[No Abstract] [Full Text] [Related]
20. [Comparison of the targeting properties of 2-deoxy-D-glucose-conjugated nanoparticles to breast cancer MDA-MB-231 cells and breast fibroblasts cells].
Wang P; Shan XH; Xiong F; Gu N; Qian H; Fan Y; Wang YF
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):566-71. PubMed ID: 24314212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
